Estrogen contributes to non-pRb targeted HPV18 E7-caused cell proliferation and transformation

Cancer Biology and Therapy

Volumn 9, Issue 3, 2010, Pages 206-215

  Yan, Xiaofei ^a   Shah, Walayat ^a   Li, Xu ^a   Wang, Yili ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

c Jun; c Myc; Cell transformation; E7; Estrogen; HPV; pRb independent

Indexed keywords

ESTROGEN; MYC PROTEIN; PROTEIN C JUN; PROTEIN E7; RETINOBLASTOMA PROTEIN;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CENTROSOME; CHROMOSOMAL INSTABILITY; CHROMOSOME DUPLICATION; CONTROLLED STUDY; GENOMIC INSTABILITY; HUMAN PAPILLOMAVIRUS TYPE 18; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; UTERINE CERVIX; UTERINE CERVIX CANCER; VIRUS CELL TRANSFORMATION;

ANIMALS; CELL ADHESION; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMAL INSTABILITY; DNA-BINDING PROTEINS; ESTROGENS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, VIRAL; HUMANS; MICE; NIH 3T3 CELLS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROTO-ONCOGENE PROTEINS C-JUN; PROTO-ONCOGENE PROTEINS C-MYC; RETINOBLASTOMA PROTEIN; UTERINE CERVICAL NEOPLASMS;

EID: 77953583367     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.9.3.10662     Document Type: Article

References (40)

1. Sankaranarayanan R, Ferlay J. Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol 2006; 20:207-25. (Pubitemid 43380597)
2. Zur Hausen H. Human papillomavirus in the pathogenesis of anogenital cancer. Virology 1991; 184:9-14.
3. Baldwin A, Huh KW, Munger K. Human papillomavirus E7 oncoprotein dysregulates steroid receptor coactivator 1 localization and function. J Virol 2006; 80:6669-77. (Pubitemid 43927469)
4. Anonymous. Invasive squamous-cell cervical carcinoma and combined oral contraceptives: results from a multinational study. WHO collaborative study of neoplasia and steroid contraceptives. Int J Cancer 1993; 55:228-36.
5. Moodley M, Moodley J, Chetty R, Herrington CS. The role ofsteroid contraceptive hormones in the pathogenesis of invasive cervical cancer: a review. Int J Gynecol Cancer 2003; 13:103-10.
6. Auborn KJ, Woodworth C, DiPaolo JA, Bradlow HL. The interaction between HPV infection and estrogen metabolism in cervical carcinogenesis. Int J Cancer 1991; 49:867-9.
7. von Knebel Doeberitz M, Bauknecht T, Bartsch D, zur Hausen H. Influence of chromosomal integration on glucocorticoid-regulated transcription of growth-stimulating papillomavirus genes E6 and E7 in cervical carcinoma cells. Proc Natl Acad Sci 1991; 88:1411-5.
8. Kim CJ, Um SJ, Kim TY, Kim EJ, Park TC, Kim SJ, et al. Regulation of cell growth and HPV genes by exogenous estrogen in cervical cancer cells. Int J Gynecol cancer 2000; 10:157-64.
9. Barbosa MS, Schlegel R. The E6 and E7 genes of HPV-18 are sufficient for inducing two-stage in vitro transformation of human keratinocytes. Oncogene 1989; 4:1529-32. (Pubitemid 20008936)
10. Villa LL, Schlegel R. Differences in transformation activity between HPV-18 and HPV-16 map to the viral LCR-E6-E7 region. Virology 1991; 181:374-7.
11. Munger K, Phelps WC, Bubb V, Howley PM, Schlegel R. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 1989; 63:4417-21.
12. Lambert P, Pan H, Pitot H, Liem A, Jaxkson M, Griep A. Epidermal cancer associated with expression of human papillomavirus type 16 E6 and E7 oncogenes in the skin of transgenic mice. Proc Natl Acad Sci 1993; 90:5583-7.
13. Arbeit JM, Munger K, Howley PM, Hanahan D. Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice. J Virol 1994; 68:4358-68. (Pubitemid 24183029)
14. Song S, Liem A, Miller JA, Lambert PF. Human papillomavirus types 16 E6 and E7 contribute differently to carcinogenesis. Virology 2000; 267:141-50. (Pubitemid 30123597)
15. Rebeccah RR, Duensing S, Brake T, Munger K, Lambert PF, Arbeit JM. Dissection of human papillomavirus E6 and E7 function in transgenic mouse models of cervical carcinogenesis. Cancer Res 2003; 63:4862-71. (Pubitemid 37022618)
16. Dyson N, Howley PM, Munger K, Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989; 243:934-7. (Pubitemid 19066153)
17. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA. Effects of and Rb mutation in the mouse. Nature 1992; 359:295-300.
18. Mulligan G, Jacks T. The retinoblastoma gene family cousins with overlapping interests. Trends Genet 1998; 14:223-9. (Pubitemid 28266973)
19. 1 arrest involves pRb-related proteins and is disrupted by the human papillomavirus 16 E7 oncoprotein. Proc Natl Acad Sci 1994; 91:5320-4.
20. Balsitis SJ, Sage J, Duensing S, Munger K, Jacks T, Lambert PF. Recapitulation of the effects of the HPV-16 E7 oncogene on mouse epithelium by somatic Rb deletion and detection of pRb-independent effects of E7 in vivo. Mol Cell Biol 2003; 23:9094-103. (Pubitemid 37499799)
21. Jewers RJ, Hildebrandt P, Ludlow W, Kell B, McCance D. Regions of human papillomavirus type 16 E7 oncoprotein required for immortalization of human keratinocytes. J Virol 1992; 66:1329-35.
22. Antinore M, Birrer M, Patel D, Nader L, McCance D. The human papillomavirus type 16 E7 gene product interacts with and transactivates the AP1 family of transcription factors. EMBO J 1996; 15:1950-60. (Pubitemid 26119228)
23. Helt A, Galloway DA. Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes. J Virol 2001; 75:6737-47. (Pubitemid 32641559)
24. Edmonds C, Vousden KH. A point mutational analysis of human papillomavirus type 16 E7 protein. J Virol 1989; 63:2650-6.
25. Balsitis S, Dick F, Lee D, Farrell LR, Hyde K, Griep AE, et al. Examination of the pRb-dependent and pRb-independent functions of E7 in vivo. J Virol 2005; 79:11392-402.
26. Chauhan A, Tikoo A, Kapur AK, Singh M. The taming of the cell penetrating domain of the HIV Tat: myths and realities. J Control Release 2007; 12:148-62.
27. Dietz GP, Bahr M. Delivery of bioactive molecules into the cell: the trojan horse approach. Mol Cell Neurosci 2004; 27:85-131.
28. Dietz GP, Kilic E, Bahr M. Inhibition of neuronal apoptosis in vitro and in vivo using TAT-mediated protein transduction. Mol Cell Neurosci 2002; 21:29-37.
29. Yan X, Walayat S, Shi Q, Zheng J, Wang Y. Development of a soluble PTD-HPV18E7 fusion protein and its functional characterization in eukaryotic cells. Acta Biochim Biophys Sin 2009; 41:900-9.
30. Davies R, Hicks R, Crook T, Morris J, Vousden K. Human papillomavirus type 16 E7 associates with a histone H1 kinase and with p107 through sequences necessary for transformation. J Virol 1993; 67:2521-8. (Pubitemid 23118846)
31. Demers GW, Espling E, Harry JB, Etscheid BG, Galloway DA. Abrogation of growth arrest signals by human papillomavirus type 16 E7 is mediated by sequences required for transformation. J Virol 1996; 70:6862-9. (Pubitemid 26307398)
32. Gonzalez SL, Stremlau M, He X, Basile JR, Munger K. Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7. J Virol 2001; 75:7583-91. (Pubitemid 32738016)
33. Duensing S, Lee LY, Duensing A, Basile J, Piboonniyom S, Gonzalez S, et al. The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle. Proc Natl Acad Sci 2000; 97:10002-7.
34. Duensing S, Munger K. Human papillomavirus type 16 E7 oncoprotein can induce abnormal centrosome duplication through a mechanism independent of inactivation of retinoblastoma protein family members. J Virol 2003; 77:12331-5. (Pubitemid 37339885)
35. Salisbury L, Whitehead CM, Lingle WL, Barrett SL. Centrosomes and cancer. Biol Cell 1999; 91:451-60.
36. Munger K, Baldwin A, Edwards KM, Hayakawa H, Nguyen CL, Owens M, et al. Mechanisms of human papillomavirus-induced oncogenesis. J Virol 2004; 78:11451-60.
37. Wang YW, Chang HS, Lin CH, Winston CY. HPV-18 E7 conjugates to c-Myc and mediates its transcriptional activity. Int J Biochem Cell Biol 2007; 39:402-12.
38. Weiss A, Cicatiello L, Persico E, Scalona M, Bresciani F. Estrogen stimulates transcriptionof c-jun protooncogene. Mol Endocrinol 1990; 4:1041-50.
39. Travers MT, Knowler JT. Oestrogen-induced expression of oncogenes in the immature rat uterus. FEBS Lett 1987; 221:27-40.
40. Fan X, Liu Y, Chen J. Activation of c-Myc contributes to bovine papillomavirus type 1 E7-induced cell proliferation. J Biol Chem 2003; 278:43163-8. (Pubitemid 37345935)